CRWV insiders report repeated 10b5-1 stock sales
Company reported multiple 10b5-1 planned sales of Common stock by insiders and related entities, listing individual transactions and share amounts.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Company reported multiple 10b5-1 planned sales of Common stock by insiders and related entities, listing individual transactions and share amounts. The filings show repeated dispositions across dates in March–June 2026, with several large lots (e.g., 200,000 shares on multiple dates) sold under 10b5-1 programs.
Insights
Multiple scheduled 10b5-1 dispositions by insiders and related trusts are disclosed.
The excerpt lists numerous 10b5-1 sales by named individuals and affiliated trusts, including repeated 200,000-share lots and smaller tranches, each with trade dates and gross values. These entries document routine, pre-arranged dispositions rather than primary issuances.
Impact is procedural: subsequent filings will show further sales or remaining positions; timing and cash‑flow recipients are not specified in the excerpt.
Key Figures
Key Terms
10b5-1 regulatory
Form 144 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the CRWV Form 144 filing show?
Who executed the stock sales in the CRWV filing?
How large were the largest transactions reported?
AI-generated analysis. How Rhea-AI works. Not financial advice.